Medical Marijuana, Inc. Investment AXIM® Biotech Announces Enrolled Patients Begin Phase II Trial For The Treatment Of Irritable Bowel Syndrome (IBS...
AXIM® Biotechnologies enrolled 40 patients and commenced its Phase II clinical trial for the treatment of IBS with CanChew Plus® CBD gum.
Continue Reading https://www.medicalmarijuanainc.com
Join the Discussion